Sign in
CompletedNo phase

Population-based Investigation of Aneurysm Incidence

Key facts

Who runs it
Beijing Tiantan Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
4,711 people enrolled
Started
1 Oct 2023
Ended
28 Feb 2025
Type of study
Interventional
Treatments tested
  • blood test
Record updated
16 May 2025

Who can take part

Age
35 years to 75 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Age 35-75
  • Individuals with normal cognitive and communication abilities
  • No serious complications, such as uncontrolled hypertension, diabetes or other chronic diseases that may affect the test results
  • Basic blood test is normal or close to normal range

Who cannot take part

  • There are metal implants, including dentures, pacemakers, etc
  • Using or recently used drugs that may affect blood biomarkers ( such as anticoagulant drugs, immunosuppressive agents, etc. )
  • Severe heart disease, renal insufficiency, liver dysfunction and other major diseases
  • In the past 6 months, there were strokes, or other types of intracranial tumors, infections and other diseases that may affect the screening results
  • There are serious mental illness or cognitive dysfunction, such as claustrophobia, unable to cooperate with the completion of the test
  • Pregnancy
  • It is currently participating in other clinical trials or has participated in other clinical trials in the past 3 months

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Most intracranial aneurysms are found accidentally in neurovascular imaging. And these inspection methods are limited by the problems of instrument fixation, radiation, time-consuming, contrast agent toxicity and so on. At present, blood test is an ideal alternative method for early diagnosis. Compared with imaging examination, it is economical, general screening and convenient. Blood test is simple to operate, easy to be accepted by patients, and less invasive. Early screening of aneurysms can be performed.

The group in the trial

  • blood test groupTreatment being tested

    Treatment: blood test

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
16 May 2025